The effects of inhibition of MMP-12 on endotoxemia and inflammation-induced blood-cerebrospinal fluid barrier (BCSFB) disruption were assessed both in vitro and in vivo. This evidence concerns the gene MMP12 and serum lipopolysaccharide activity.